PathGen to Develop Pathogen Detection Test Based on Affymetrix's GeneChip | GenomeWeb

NEW YORK (GenomeWeb News) – Singapore's PathGen Dx will develop a pathogen detection diagnostic kit based on the Affymetrix GeneChip platform, the companies said today.

PathGen Dx, a spinoff from the Genome Institute of Singapore, plans to develop a test called the PathChip that will detect the presence of more than 70,000 viral and bacterial genomes in human samples and identify co-infecting pathogens.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.